Nucleix Ltd.: Clinical Trials

2 trials sponsored by Nucleix Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Nucleix Ltd.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
Bladder EpiCheck Urine Test, Cystoscopy and pathology - Bladder Cancer
Not applicableCompletedNucleix Ltd.6802016-09-012021-05-04
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
Bladder EpiCheck - Bladder Cancer
Not applicableCompletedNucleix Ltd.10502015-12-012021-05-04

Conditions studied

Urinary Bladder Neoplasms (2)

Interventions

Cystoscopy (1)

Countries

Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Fred Witjes, Prof. (1)  ·  Shmulik Adler (1)  ·  Shmulik Adler, MSc (1)